Back
CVB Financial Vs. Apellis Pharmaceuticals Industry Stock Comparison
Sell
41
CVBF
CVB Financial
Last Price:
23.09
Seasonality Move:
2.04%
Buy
51
APLS
Apellis Pharmaceuticals
Last Price:
29.61
Seasonality Move:
22.1%
Sell
41
CVB Financial (CVBF)
is a Sell
Is CVB Financial a Buy, Sell or Hold?
- The current CVB Financial [CVBF] share price is $22.00. The Score for CVBF is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- CVBF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
51
Apellis Pharmaceuticals (APLS)
is a Buy
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
- The current Apellis Pharmaceuticals [APLS] share price is $30.02. The Score for APLS is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- APLS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CVBF Stock Price Chart
What is CVB Financial's stock price today?
-
The CVB Financial share price today is $22.00
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CVBF is experiencing slight buying pressure.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $30.02
The current trend is relatively stagnant and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.
CVBF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.78 | Buy |
| Relative Strength Index (14 RSI): | 68.42 | Buy |
| Chaikin Money Flow: | 296597 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.2 - 20.54) | Buy |
| Bollinger Bands (100): | (16.89 - 19.35) | Buy |
APLS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.4 | Sell |
| Relative Strength Index (14 RSI): | 58.06 | Buy |
| Chaikin Money Flow: | 2150169 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.93 - 28.43) | Buy |
| Bollinger Bands (100): | (29.7 - 39.56) | Sell |
CVBF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.37 | Buy |
| 20-day SMA: | 19.71 | Buy |
| 50-day SMA: | 18.57 | Buy |
| 200-day SMA: | 17.52 | Buy |
| 8-day EMA: | 20.75 | Buy |
| 20-day EMA: | 19.84 | Buy |
| 50-day EMA: | 18.92 | Buy |
| 200-day EMA: | 17.98 | Buy |
APLS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.4 | Buy |
| 20-day SMA: | 27.8 | Buy |
| 50-day SMA: | 31.23 | Sell |
| 200-day SMA: | 44.21 | Sell |
| 8-day EMA: | 28.61 | Buy |
| 20-day EMA: | 28.43 | Buy |
| 50-day EMA: | 30.68 | Sell |
| 200-day EMA: | 40.64 | Sell |
CVB Financial Earnings Growth & CVBF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and a decrease next year of $0.03 per share.
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.75 per share, and an increase next year of $0.83 per share.
CVB Financial Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Apellis Pharmaceuticals Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||